Photo: Sundry Photography/Getty Images Kaiser Permanente's Dr. Daniel Yang, who is vice president of artificial intelligence and emerging technologies, told The Wall Street Journal in an interview published yesterday that he wouldn't feel comfortable using AI to automate clinical decision making in diagnosis or treatment. Infrastructure for AI has not kept up with development, Yang said.
The haves - the large health systems such as Kaiser, have the scale for AI implementation while smaller, rural health systems do not have the same advantages, he told WSJ . WHY THIS MATTERS Kaiser is using AI to its fullest advantage in a large implementation of AI scribe and also in partnership with Abridge for generative AI clinical documentation. Last week Kaiser announced that Abridge is now available at its 40 hospitals and more than 600 medical offices in eight states and the District of Columbia.
The tool is powered by ambient listening technology that captures clinical notes so that physicians spend more time with patients than on documentation. The assisted clinical-documentation tool uses AI to summarize relevant medical information from spoken, natural conversations. The tool requires patient consent, and doctors and clinicians review the clinical notes before entering them into a patient's medical record.
THE LARGER TREND Kaiser Permanente announced the system-wide implementation after almost a year of testing and evaluation. Abridge is compliant with state and federal privacy law.